Intel Israel has new CEO

Fassberg is Intel Israel's first female CEO and will be responsible for leading an operation with some 6,800 employees at five locations in the country.

By MATTHEW KRIEGER
June 11, 2007 07:36

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Maxine Fassberg was introduced as Intel Israel's new CEO on Sunday, replacing Alex Kornhauser, who will takeover as CEO of the newly formed company Intel is creating with STMicroelectronics and Francisco Partners. Fassberg, who has been at parent company Intel Corp. for some 23 years and most recently held the position of vice president of technology manufacturing for the parent, will also head up Intel Israel's new Fab-28 plant currently under construction in Kiryat Gat. Fassberg is Intel Israel's first female CEO and will be responsible for leading an operation with some 6,800 employees at five locations in the country.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS